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Costs of Stroke in Sweden
Background and Purpose Cost-effectiveness analyses of stroke management are hampered by paucity of economic data. We made an update of the direct and indirect costs of stroke in Sweden (population, 8.5 million).
Methods Direct costs (ie, the costs for hospital and outpatient care and social services) were estimated on the basis of two prospective population-based studies of stroke and of two nationwide cross-sectional inventories of bed-days and diagnoses. Indirect costs (ie, the costs for loss of productivity and early retirement) were based on official statistics.
Results The direct annual costs of care for stroke patients in 1991 equaled 7836 million Swedish krona (SKr) ($1306 million in US dollars), and the indirect costs, 2430 million SKr T he rapidly growing body of knowledge from randomized trials on the effects of various aspects of prevention and management of stroke provides one important prerequisite for costeffectiveness analysis. However, there are as yet few analyses of costs in relation to the gains in stroke management. Such analyses are hampered by the paucity of accurate and up-to-date economic data on stroke. Estimations of the costs of stroke have been performed in the United States, 14 the United Kingdom, 5 - 7 and Sweden.
8 " 10 Many of these studies are based on data from the 1970s, and only three of them 2 " 4 include indirect costs, ie, cost of absenteeism, diseaserelated early retirement, and death before the age of 65.
Based on incidence data, 11 it can be calculated that 33 000 people suffer from stroke each year in Sweden. Of this annual total, 25 000 experience stroke for the first time. 11 As part of its work to critically assess central issues in Swedish health care, the Swedish Council on Technology Assessment in Health Care has reviewed the state of the art in stroke prevention and management (Table  1 , source A). The aim was to define and promote those procedures that are of documented value and to identify useless and questionable procedures in routine care of stroke patients in Sweden. An important component of the evaluation has been to assess the costs of stroke itself. We report here on the results of these assessments, using a national perspective and including both direct and indirect costs.
Subjects and Methods
A large number of sources provide background data in the study. Many of the sources have been compiled by Swedish healthcare authorities and other official agencies and are not available in the international scientific literature. These sources are listed in Table 1 and are referred as to source A, source B, etc, in the text.
Direct Costs Per Patient
The incidence approach has been used to estimate direct costs. The incidence approach assigns all direct and indirect costs to the calendar year in which the stroke occurred. 3 For example, a patient has a stroke in 1983, and he lives handicapped until 1990. He cannot work, and he needs hospital care in periods and home help in between. All costs of this patient until he dies will, according to the incidence approach, be assigned to the year his stroke occurred, 1983. The prevalence approach, which assigns the costs to the calendar years in which they occur, 3 was used only for estimating costs of absenteeism (sickness benefit) in the present investigation. According to the prevalence approach, the costs of absenteeism in our example are based on all persons receiving sickness benefits in 1983 because of stroke, irrespective of whether their stroke occurred in 1983 or a previous year.
To estimate direct costs for individual stroke patients, data from two population-based Swedish studies were used. The first was the Soderhamn stroke register study, which was started in 1975 and has since been updated regularly.
11 ' 12 The study covers a population of 30 000 in a small town and the surrounding rural area in central Sweden. The population is served by a single community hospital. About 80% of the stroke patients are admitted to the Department of Medicine, and the rest are identified by active case identification in the population. Screening for stroke patients is performed weekly No. of sickness-benefit days because of stroke on hospital wards, in nursing homes, in assisted-living homes, at the offices of general practitioners, and in the centers for home-help services. Death certificates are also scrutinized. The patients included in this study (162 men and women with first-ever stroke, including patients with subarachnoid hemorrhage) were registered in 1983 through 1984 and were followed up for 2 years. Their mean age was 75 years.
The second study, the Lund-Orup survey, covering a population of 200 000 inhabitants, was performed in 1983 in the south of Sweden. 9 A random sample of patients admitted to the Department of Neurology, Lund University Hospital, because of first-ever stroke was chosen for the economic study. These 125 patients were good representatives of all stroke patients in the background population with one exception only: patients with subarachnoid hemorrhage were not included. 13 The follow-up of these patients lasted for 2 years. Their mean age was 73 years.
In both studies, costs during the first and second year after stroke have been separated. In the present investigation, annual stroke-related costs per patient were assumed to be constant after the second year. The number of patients, however, gradually decreased. Life tables of stroke patients covering 8 years of follow-up were obtained from another community-based Swedish study. 14 The tables were extrapolated up to 15 years, by which time it was assumed that all patients had died. In addition, the following assumptions were made: the cost for an individual patient is constant from the second year onward, and the discount rate is 5%. The annual growth of productivity was set at 1.5%.
In the Soderhamn stroke register study, information on costs of health care and social services during the year preceding the stroke is available. 15 This makes it possible to calculate the costs that are added to prestroke costs, ie, how large the stroke-related costs are.
Direct Costs, National Level
The prevalence approach was used to estimate the total direct costs on the national level. Information on the total number of hospital beds occupied by stroke patients was obtained from the National Board of Health and Welfare for 1988, the most recent year for which routine statistics are available (Table 1 , source B). Data were subdivided by type of ward. This information was validated using a cross-sectional inventory performed by the Association of County Councils in all Swedish hospitals on one specific day in 1988 (sources C and D). In both analyses, only patients with stroke as the major cause of admission were included.
The number of outpatient visits for stroke was based on statistics at one local healthcare center in central Sweden (source E) and one university hospital in Stockholm (source F).
Indirect Costs
All indirect costs except cost for absenteeism have been estimated by the incidence approach. Thus, loss of productivity because of early retirement (Table 1 , source I) and early death is calculated by its present value from the onset of the disease up to the year of regular retirement (in Sweden, at the age of 65). Estimates of the total value of loss of productivity were based on mean annual salaries, social costs, and employers' fees for each 10-year age group divided by the number of working days per year. Costs for absenteeism were based on all persons receiving sickness benefits because of stroke in 1983 (source J).
Unitary Costs
The unitary costs of health care and social services are shown in Table 2 . Mean costs per hospital day and per outpatient visit, by type of clinic in both instances, were obtained from the official statistics of the Federation of Swedish County Councils (Table 1 , source G). Costs of social services, assistive devices, and household modifications have been derived from the Soderhamn study. including hospital wards for nursing care. tNursing beds outside hospital.
Results

Direct Costs Per Patient
Many elderly stroke patients require hospital care and social services even if they do not have a cerebrovascular event. Thus, many patients already have baseline costs when stroke occurs. We therefore separated "costs of a stroke patient," which includes all costs from first-ever stroke to death, from "direct strokerelated costs." The direct stroke-related costs are costs added to baseline (prestroke) costs.
The estimated mean costs of a stroke patient in the two population-based studies of first-ever stroke are shown in Table 3 . Total costs during the first year after first-ever stroke were 24% higher in the Lund-Orup area than in Soderhamn because more hospital days were used and the cost per hospital day was higher. During the second year, the difference was only 13%. The total direct costs of a stroke patient, derived from the Soderhamn data and extrapolated to 15 years, were estimated at 440 000 SKr ($73 333), using a 5% discount rate.
In Soderhamn, the cost in the year preceding the stroke was high and on average amounted to more than half of the total cost during the first and second follow-up years ( Table 4 ). The costs added by a first stroke were then estimated at 63 080 SKr ($10 513) during the first year and 47 080 SKr ($7847) during the second.
When these figures are extrapolated to 15 years and sums not directly related to the stroke are deducted, the lifetime cost was reduced from 440 000 SKr ($73 333) to 180 000 SKr ($30 000).
Direct Cost, National Level
According to official hospital statistics, a total of approximately 3 million bed-days were recorded for patients with acute cerebrovascular disease as the main diagnosis at discharge in Swedish hospitals in 1988 ( Table 5 ). The great majority of hospital beds for stroke patients were in geriatric and medical wards. Using average costs per bed in different types of wards, according to their proportion of the total, we estimated the annual cost for in-hospital care of stroke patients in Sweden at 5135 million SKr ($856 million).
The 1-day national inventory performed in 1988 found that 23% of all patients in Swedish hospital wards, including departments for long-term nursing care, had a diagnosis of cerebrovascular disease. The total number of hospital beds was 49 000, with a mean occupancy rate of 92%. (Ten thousand of these beddays were assigned to nursing care.) On the basis of this background information, the number of stroke-related bed-days was calculated to be 3.8 million per year. This is 25% higher than the estimate based on hospital discharge diagnoses. There are technical reasons for this discrepancy, the most obvious being that, if a patient stays longer than 1 year in the hospital, he or she is not listed in the discharge register. If we assume that those patients staying more than 1 year in geriatric wards account for the total difference shown between the two methods of collecting data, the total annual cost for hospital care of stroke patients would be 6156 million SKr ($1026 million) when the inventory data are used. This is equivalent to 724 SKr ($121) per inhabitant.
Another method to estimate costs for hospital care is to base the calculations on incidence data from epidemiological studies in Sweden incurred before the stroke indicates that the costs for direct stroke-related hospital care would be 3161 million SKr ($527 million). On the other hand, if calculations are based on the results of the Lund-Orup study, the total annual costs for hospital care of stroke patients (stroke due to events of concurrent diseases and events directly related to stroke) would be 10 275 million SKr ($1713 million), which is considerably higher than in the other estimates. Thus, in three approaches, the total costs for stroke patients in Sweden ranged from 5135 to 10 275 million SKr ($856 to $1713 million). The costs estimated by the second approach, the national inventory, came close to the costs based on the Soderhamn study. They were judged to represent a conservative measure of the costs for hospital care. The national inventory, giving the lowest cost of the two, was chosen for the final calculations (Table 6) .
Based on detailed statistics from a local healthcare center and the outpatient department of a large hospital, the total annual number of outpatient visits for the late effects of stroke in the country was estimated to be 100 000 at the offices of general practitioners and 50 000 at hospitals. The total cost for all outpatient visits was then calculated to be 130 million SKr ($22 million) ( Table 6 ). When data are extrapolated from the population-based studies, the expense for outpatient visits would range from 87 million SKr ($15 million) (LundOrup) to 225 million SKr ($38 million) (Soderhamn).
The two population-based studies from Soderhamn and Lund-Orup also provide information on the cost of social services for stroke patients. These costs differed greatly. In Soderhamn, where costs for hospital care were relatively low, the expenses for social services were twice as high as in Lund-Orup (Table 3) . To arrive at a crude estimate of social costs at the national level, social services were assumed to account for 25% of the costs for hospital care during the first 2 years after stroke, as they did in the Soderhamn study where all patients, not only those hospitalized, were followed up. The total annual costs for social services in Sweden would then be 1550 million SKr ($258 million).
Indirect Costs
Information on the number of days of sickness benefit for stroke was available up to 1983. A total of 550 000 working days per year were lost because of stroke. The value of each day lost for productivity was estimated at 940 SKr ($156). Consequently, the cost for loss of productivity was 515 million SKr ($86 million).
In Sweden, approximately 700 people are granted early retirement every year because of stroke. There are approximately 5400 approved cases of early retirement for the same reason. This corresponds to a cost for productivity loss of 950 million SKr per year ($158 million).
In 1987, 662 patients died from stroke before the age of 65 in Sweden. Knowing their age distribution, we calculated the number of production years lost to be 7218. The total cost of loss of productivity due to early death from stroke was estimated at 965 million SKr ($161 million).
Thus, total indirect costs for stroke were estimated at 2430 million SKr ($405 million) per year.
Total National Costs of Stroke
The estimates of national costs of stroke are summarized in Table 6 . When two or more alternative approaches to measure costs were used, the results that were best validated in our opinion were chosen for summarizing analyses. The total cost was estimated to be 10 266 million SKr ($1711 million) nationwide and 1208 SKr ($201) per inhabitant.
As demonstrated above, different methods to calculate costs at the national level give varying results. If the lowest costs for each item were used throughout, the total annual cost would be 9202 million SKr ($1534 million). If the highest alternative was used instead, this would result in a grand total of 14 480 million SKr ($2413 million).
If only direct stroke-related costs (after deduction of prestroke costs) were used, the direct costs would be reduced by approximately 4630 million SKr ($772 million). This corresponds to a reduction of the stroke costs per inhabitant by 548 SKr ($91). Our data sources do not provide information on how large a proportion of the indirect cost for stroke patients is immediately related to stroke.
Discussion
The estimation of stroke costs on the national level is greatly dependent on the quality and precision of the by guest on September 21, 2017 http://stroke.ahajournals.org/ Downloaded from data used. To reduce bias, we found it necessary to use all kinds of information available. Thus, our analyses are a mixture of incidence-and prevalence-based estimates. Whether the incidence or prevalence methodology is the more relevant depends on the purpose of the analysis. 3 For decision makers concerned with controlling current medical costs and absenteeism, the prevalence approach is judged superior. For decision makers evaluating and ameliorating preventive programs, the prevalence approach is misleading because it focuses on current costs. In this case, the incidence method is more relevant. 3 The validity of hospital discharge data has been questioned. 19 On the other hand, register data, which emerge from small prospective studies, will increase the risk for sampling error due to small numbers. 20 In our study, both discharge and register data were used to minimize these kinds of bias. Comparing costs of stroke from one time period to another is also complicated, especially in an international perspective. The inflation rate over a prolonged period differs markedly between countries. Consequently, conversion of previous costs to the current monetary value by the use of the consumer price index may introduce bias. Furthermore, the exchange rate of Swedish kronas to US dollars has fluctuated considerably since 1992. Thus, for comparison, our cost data have been converted to the 1991 value only. During the period covered by our study, the exchange rate of Swedish kronas to US dollars was more stable than later on.
The estimation of stroke costs in different countries will give different results not only because of varying validity of background data and different rates of inflation but also because of medicosocial differences. The syndrome of stroke is etiologically heterogeneous, and the underlying cause is age dependent. Subarachnoid hemorrhage is more common in the young patient, intracerebral hemorrhage in the middle-aged, and cerebral infarct in the elderly.
182123 These differing etiologies lead to different prognoses for survival and functional disability. 24 ' 25 Consequently, differences in age distribution between countries have an impact on the national costs of stroke. The population of Sweden is one of the oldest in the world, with 18% above 65 years of age. 26 Previous studies have shown that stroke is one of the disorders of highest cost to societies in industrialized countries. 3 Because stroke is largely a disease of the elderly, many patients are already disabled by other diseases at the time of their first attack.
2729 These comorbid diseases also may have an impact on the need for assistance after stroke. The advanced age of the population of Sweden 26 results in high premorbid costs, as found in the present study. These premorbid costs may be relatively higher than in countries with essentially younger stroke populations.
On the other hand, the proportion of indirect costs (ie, costs incurred for sickness benefit, early retirement, and death before the age of 65) may be more modest in the more elderly Swedish population than in younger ones. In other costly disorders such as myocardial infarction, cancer, and traffic accidents, indirect costs account for 70% of total costs. 3 Our present data show that only 24% of the costs for stroke are indirect. In previous reports comprising data from younger populations, the proportion of indirect costs has been considerably higher at 46% to 63%. 2 4 Estimating indirect costs is, in general, an unsolved problem in health economics. The theory of indirect cost is based on several assumptions. A perfectly functioning market and no unemployment are two of the cornerstones on which this theory is built. Thus, the validity of indirectcost estimates may be less than the validity of estimates of direct costs in our work.
In Sweden, a greater proportion of young and middleaged women are working outside their homes than in other countries. Thus, young family members of Swedish stroke victims take part in the care of their parents only to a limited extent. In the Soderhamn study, only 8% of the children assisted their parents after stroke (A.T., unpublished data, 1988). On the other hand, if more family members remain at home to care for their stroke-ridden parent, the cost of social services will appear to be less. In complete economic analyses, however, these private services should be estimated. Usually, they are counted as the loss of income due to absenteeism. We have not made such efforts in the present study.
Case fatality after stroke is comparatively low in Sweden, which provides another possible explanation for the high direct costs. In the MONICA study, in which 19 middle-aged populations were compared, Sweden had the lowest 28-day case fatality ratio in men and the second lowest in women. 30 This means that there are more stroke survivors than in many other populations, which may have a bearing on costs.
The total direct costs of stroke found in this study may seem high in an international perspective. When inflation is taken into account (30% between 1988 and 1991), the direct costs are six times those reported in Scotland in 1988. 7 Quite different approaches to estimate the costs of stroke were used, however. The Scottish figures were based on discharge diagnoses and the Swedish figures on expected lifetime costs. This makes direct comparisons difficult. By limiting the comparison to direct costs per person discharged, the relation between Swedish and Scottish figures is reduced to 1.6. Other comparisons are hampered by the lack of breakdown of national costs to costs per patient, with one exception. In 1975, the expenditure per stroke patient was $23 000 in the US state of Massachusetts 2 compared with $20 640 in Soderhamn, Sweden, in 1977. 8 The payment for stroke in the diagnosis related grouping (DRG) was $4016 in the United States in 1985. 31 This sum was paid for an average stay of 5 to 10 days in the hospital. Thus, the average cost per bed-day was $268 to $402. The 1985 Swedish cost per bed-day ranged from $250 (medicine) to $289 (neurology) in US dollars at the exchange rate of that year. It therefore seems that the hospital costs per day for stroke patients are not higher in Sweden than in the United States.
Costs should, in general, be related to what they give in return to the patient, his or her family, and society. For stroke, there is a plethora of documented and undocumented methods to prevent, diagnose, nurse, treat, and rehabilitate. International comparisons of cost-effectiveness or cost-benefit in stroke care may help to cast new light on which methods are better than others. The present study is one step toward promoting international comparisons that will permit us to find the most cost-efficient strategies in stroke management.
